#USA #Columbus #PAVmed #Veris Health #OSUCCC

PAVmed and OSUCCC Begin Commercial Phase of Strategic Partnership

PAVmed Inc., recognized as a pioneering medical technology company, has announced a pivotal development in its partnership with The Ohio State University Comprehensive Cancer Center (OSUCCC) – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute. This alliance, which aims to revolutionize cancer treatment, has now entered its commercial phase, marking a significant milestone in advancing personalized cancer care through innovative technology.

A Commitment to Personalized Cancer Care

Brian deGuzman, M.D., Chief Operating Officer of Veris Health, PAVmed’s majority-owned subsidiary, emphasized the importance of this partnership in enhancing personalized cancer care. By collaborating with OSUCCC, one of the nation’s leading academic cancer centers, the organizations aim to deploy the Veris Cancer Care Platform to facilitate better healthcare outcomes for patients undergoing systemic cancer therapies. Dr. deGuzman noted, "This represents an important milestone on the path towards reaching Veris' long-term commercial potential."

The Veris Cancer Care Platform Explained

At the core of this initiative is the Veris Cancer Care Platform, a comprehensive digital solution designed for cancer patients. It incorporates remote physiological data collection, symptom reporting, and telehealth capabilities, all integrated into electronic health records. This platform is focused on fostering early detection of complications, minimizing unplanned hospital visits, and providing a seamless connection between patients and their healthcare teams.

Patients enrolled in this program will receive a VerisBox™, which contains connected healthcare devices that communicate physiological data to healthcare providers via a secure cloud-based portal. This system not only allows for real-time monitoring but also enhances patient involvement in their healthcare journey through an app. The app permits patients to report symptoms and share health updates with their cancer care team, while also enabling family members or caretakers to participate in the care process.

Expanding Capabilities: The Implantable Physiological Monitor

Looking towards the future, Veris Health is in the process of developing an implantable physiological monitor. This innovative device is expected to be implanted alongside vascular access ports and will function synergistically with the Veris Cancer Care Platform, creating an even more comprehensive solution for tracking patient health. By providing continuous physiological data, the monitor will eliminate dependence on patient compliance, ensuring that critical health information reaches healthcare professionals in real time.

A Testament to Innovation at OSUCCC – James

The Ohio State University Comprehensive Cancer Center is renowned for its commitment to delivering pioneering cancer care. As an NCI-designated comprehensive cancer center, it stands out as a leader in both clinical trials and innovative treatment methods. Dr. David Cohn, Chief Operating Officer and Chief Medical Officer at OSUCCC – James, articulated the hospital's mission, stating, "At the OSUCCC – James, our mission is to deliver innovative, personalized cancer care to every patient." The recent expansion of this strategic partnership highlights OSUCCC – James's commitment to leveraging technology to enhance patient care beyond traditional clinical settings.

Looking Forward: Collaborative Research and Development

This partnership not only signifies a commercial collaboration but also paves the way for extensive research and development initiatives between PAVmed and OSUCCC. Both entities aim to explore new methodologies for improving cancer care through technology-driven insights, reinforcing their positions at the frontier of cancer research.

For more information on PAVmed and their initiatives in the medical technology field, as well as the capabilities of the innovative Veris Cancer Care Platform, visit PAVmed and Veris Health. For insights into the OSUCCC – James and its cancer treatment protocols, head to cancer.osu.edu.